These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 14631332)

  • 1. Extreme subcutaneous insulin resistance: a misunderstood syndrome.
    Soudan B; Girardot C; Fermon C; Verlet E; Pattou F; Vantyghem MC
    Diabetes Metab; 2003 Nov; 29(5):539-46. PubMed ID: 14631332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcutaneous insulin resistance successfully circumvented on long term by peritoneal insulin delivery from an implantable pump in four diabetic patients.
    Riveline JP; Vantyghem MC; Fermon C; Brunet C; Gautier JF; Renard E; Charpentier G;
    Diabetes Metab; 2005 Nov; 31(5):496-8. PubMed ID: 16357794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The Impact of Prolonged Use of Continuous Subcutaneous Insulin Infusion in the Control of Type-1 Diabetes].
    Azevedo S; Saraiva J; Caramelo F; Fadiga L; Barros L; Baptista C; Melo M; Gomes L; Carrilho F
    Acta Med Port; 2019 Feb; 32(1):17-24. PubMed ID: 30753799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycemic parameters with multiple daily injections using insulin glargine versus insulin pump.
    Garg SK; Walker AJ; Hoff HK; D'Souza AO; Gottlieb PA; Chase HP
    Diabetes Technol Ther; 2004 Feb; 6(1):9-15. PubMed ID: 15000764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes.
    Willi SM; Planton J; Egede L; Schwarz S
    J Pediatr; 2003 Dec; 143(6):796-801. PubMed ID: 14657831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extreme insulin resistance: clinical management by external subcutaneous insulin infusion.
    Lalej-Bennis D; Selam JL; Fluteau-Nadler S; M'Bemba J; Reach G; Sorel G; Bardin C; Zirinis P; Chast F; Elgrably F; Slama G
    Diabetes Metab; 1997 Dec; 23(6):533-6. PubMed ID: 9496561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of glycaemic control in type 1 diabetes during intensified therapy with multiple daily insulin injections or continuous subcutaneous insulin infusion: importance of blood glucose variability.
    Pickup JC; Kidd J; Burmiston S; Yemane N
    Diabetes Metab Res Rev; 2006; 22(3):232-7. PubMed ID: 16389648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of glycaemic control in patients with Type 1 diabetes commencing continuous subcutaneous insulin infusion therapy.
    Shalitin S; Gil M; Nimri R; de Vries L; Gavan MY; Phillip M
    Diabet Med; 2010 Mar; 27(3):339-47. PubMed ID: 20536498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials.
    Pala L; Dicembrini I; Mannucci E
    Acta Diabetol; 2019 Sep; 56(9):973-980. PubMed ID: 30945047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous subcutaneous insulin infusion attenuated glycemic instability in preschool children with type 1 diabetes mellitus.
    Alemzadeh R; Palma-Sisto P; Holzum M; Parton E; Kicher J
    Diabetes Technol Ther; 2007 Aug; 9(4):339-47. PubMed ID: 17705689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined improvements in implantable pump technology and insulin stability allow safe and effective long term intraperitoneal insulin delivery in type 1 diabetic patients: the EVADIAC experience.
    Gin H; Renard E; Melki V; Boivin S; Schaepelynck-Bélicar P; Guerci B; Selam JL; Brun JM; Riveline JP; Estour B; Catargi B;
    Diabetes Metab; 2003 Dec; 29(6):602-7. PubMed ID: 14707889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control.
    DeVries JH; Snoek FJ; Kostense PJ; Masurel N; Heine RJ;
    Diabetes Care; 2002 Nov; 25(11):2074-80. PubMed ID: 12401759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Insulin Pump Therapy vs Insulin Injection Therapy With Severe Hypoglycemia, Ketoacidosis, and Glycemic Control Among Children, Adolescents, and Young Adults With Type 1 Diabetes.
    Karges B; Schwandt A; Heidtmann B; Kordonouri O; Binder E; Schierloh U; Boettcher C; Kapellen T; Rosenbauer J; Holl RW
    JAMA; 2017 Oct; 318(14):1358-1366. PubMed ID: 29049584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of continuous subcutaneous insulin infusion and daily supplemental insulin glargine injection in children with type 1 diabetes.
    Alemzadeh R; Parton EA; Holzum MK
    Diabetes Technol Ther; 2009 Aug; 11(8):481-6. PubMed ID: 19698060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: a randomized open crossover trial.
    Weintrob N; Benzaquen H; Galatzer A; Shalitin S; Lazar L; Fayman G; Lilos P; Dickerman Z; Phillip M
    Pediatrics; 2003 Sep; 112(3 Pt 1):559-64. PubMed ID: 12949284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion.
    Lepore G; Bonfanti R; Bozzetto L; Di Blasi V; Girelli A; Grassi G; Iafusco D; Laviola L; Rabbone I; Schiaffini R; Bruttomesso D;
    Nutr Metab Cardiovasc Dis; 2018 Apr; 28(4):335-342. PubMed ID: 29428572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensor-augmented pump therapy lowers HbA(1c) in suboptimally controlled Type 1 diabetes; a randomized controlled trial.
    Hermanides J; Nørgaard K; Bruttomesso D; Mathieu C; Frid A; Dayan CM; Diem P; Fermon C; Wentholt IM; Hoekstra JB; DeVries JH
    Diabet Med; 2011 Oct; 28(10):1158-67. PubMed ID: 21294770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized controlled trial of insulin pump therapy in young children with type 1 diabetes.
    Fox LA; Buckloh LM; Smith SD; Wysocki T; Mauras N
    Diabetes Care; 2005 Jun; 28(6):1277-81. PubMed ID: 15920039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of resistance to subcutaneous insulin with implanted insulin infusion pumps].
    Löchli S; Campbell I; Dorenboos H; Paterson KR; Devlin JG; Hagmüller G; Irsigler K
    Dtsch Med Wochenschr; 1988 Sep; 113(36):1390-3. PubMed ID: 3138098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of continuous subcutaneous insulin infusion (CSII) and multiple daily injections (MDI) in paediatric Type 1 diabetes: a multicentre matched-pair cohort analysis over 3 years.
    Jakisch BI; Wagner VM; Heidtmann B; Lepler R; Holterhus PM; Kapellen TM; Vogel C; Rosenbauer J; Holl RW;
    Diabet Med; 2008 Jan; 25(1):80-5. PubMed ID: 18199134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.